Venous thromboembolism in morbid obesity and trauma: A review of literature

Minerva Chirurgica

Volumn 60, Issue 5, 2005, Pages 391-399

  Frezza, E E ^a   Chiriva Internati, M ^a  

^a TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER SCHOOL OF MEDICINE   (United States)

Author keywords

Anticoagulants; Heparins; Heparins, low molecular weight; Leg compression; Obesity; Pulmonary embolism; Trauma; Venous thrombosis

Indexed keywords

AMIODARONE; BARBITURIC ACID DERIVATIVE; CARBAMAZEPINE; CHLORDIAZEPOXIDE; CIMETIDINE; CLOFIBRATE; COLESTYRAMINE; COTRIMOXAZOLE; DALTEPARIN; ENOXACIN; ENOXAPARIN; ERYTHROMYCIN; FLUCONAZOLE; GRISEOFULVIN; HEPARIN; ISONIAZID; LOW MOLECULAR WEIGHT HEPARIN; METRONIDAZOLE; NAFCILLIN; OMEPRAZOLE; PHENYLBUTAZONE; PIROXICAM; PROPAFENONE; PROPRANOLOL; RIFAMPICIN; SUCRALFATE; SULFINPYRAZONE; TINZAPARIN; UNINDEXED DRUG; WARFARIN;

ANTICOAGULATION; DEEP VEIN THROMBOSIS; DISABILITY; DRUG EFFICACY; DRUG SAFETY; HIGH RISK POPULATION; HUMAN; INJURY; LEG COMPRESSION; LUNG EMBOLISM; MORBID OBESITY; PROPHYLAXIS; REVIEW; VENOUS THROMBOEMBOLISM;

HUMANS; OBESITY, MORBID; RISK FACTORS; THROMBOEMBOLISM; WOUNDS AND INJURIES;

EID: 27844444652     PISSN: 00264733     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (41)

1. rd. Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study. Arch Intern Med 1998;158: 585-93.
2. Wessler S, Freiman DG, Ballon JD, Katz JH, Wolff R, Wolf E. Experimental pulmonary embolism with serum-induced thrombi. Am J Path 1961;38:89-101.
3. Aschwanden M, Labs KH, Engel H. Acute deep vein thrombosis: early mobilization does not increase the frequency of pulmonary embolism. Thromb Haemost 2001;85:42-6.
4. Lensing AW, Prins MH, Davidson BL, Hirsh J. Treatment of deep venous thrombosis with low-molecular-weight heparins. A meta-analysis. Arch Intern Med 1995;155: 601-7.
5. Hull RD, Raskob GE, Pineo GF, Green D, Trowbridge AA, Elliott CG et al. Subcutaneous low-molecular-weight heparin compared with continuous intravenous heparin in the treatment of proximal-vein thrombosis. N Engl J Med 1992;326:975-82.
6. Merli G, Spiro TE, Olsson CG, Abildgaard U, Davidson BL, Eldor A et al. Subcutaneous enoxaparin once or twice daily compared wit intravenous unfractionated heparin for treatment of venous thromboembolic disease. Ann Intern Med. 2001;134:191-202.
7. Harrison L, Johnston M, Massicotte MP, Crowther M, Moffat K, Hirsh J. Comparison of 5-mg and 10-mg loading doses in initiation of warfarin therapy. Ann Intern Med 1997;126:133-6.
8. Aithal GP, Day CP, Kesteven PKL, Daly AK. Association of polymorphisms in the cytochrome P450 CYP2C9 with warfarin dose requirement and risk of bleeding complications. Lancet 1999;353:717-9.
9. Hyers TM, Agnelli G, Hull RD. Antithrombotic therapy for venous thromboembolism disease. Chest. 2001;119 Suppl:176S-209S.
10. Geerts WH, Code KI, Jay RM, Chen E, Szalai JP. A prospective study of venous thromboembolism after major trauma. N Engl J Med 1994;331:l601-6.
11. Mismetti P, Laporte S, Darmon JY, Buchmuller A, Decousus H. Meta-analysis of low molecular weight heparin in the prevention of venous thromboembolism in general surgery. Br J Surg 2001;88:913-30.
12. O'Donnell M, Weitz JI. Thromboprophylaxis in surgical patients. Can J Surg 2003;46:129-35.
13. Elliott CG, Dudney TM, Egger M, Orme JF, Clemmer TP, Horn SD et al. Calf-thigh sequential pneumatic compression compared with plantar venous pneumatic compression to prevent deep-vein thrombosis after non-lower extremity trauma. J Trauma 1999;47:25-32.
14. Nurmohamed MT, Verhaeghe R, Haas S, Iriarte JA, Vogel G, van Rij AM et al. A comparative trial of a low molecular weight heparin (enoxaparin) versus standard heparin for the prophylaxis of postoperative deep vein thrombosis in general surgery. Am J Surg 1995;169;567-571.
15. Macdonald RL, Amidei C, Baron J, Weir B, Brown F, Erickson RK et al. Randomized, pilot study of intermittent pneumatic compression devices plus delteparin versus intermittent pneumatic compression devices plus heparin for prevention of venous thromboembolism in patients undergoing craniotomy. Surg Neurol 2003;59:363-72.
16. Geerts WH, Jay RM, Code KI, Chen E, Szalai JP, Saibil EA et al. A comparison of low-dose heparin with low-molecular-weight heparin as prophylaxis against venous thromboembolism after major trauma. N Engl J Med 1996;335:701-7.
17. Knudson MM, Morabito D, Paiement GD, Shackleford S. Use of low molecular weight heparin in preventing thromboembolism in trauma patients. J Trauma 1996;41:446-59.
18. Spinal Cord Injury Thromboprophylaxis Investigators. Prevention of venous thromboembolism in the acute treatment phase after spinal cord injury: a randomized, multicenter trial comparing low-dose heparin plus intermittent pneumatic compression with enoxaparin. J Trauma 2003;54:1116-24.
19. Shorr AF, Ramage AS. Enoxaparin for thromboprophylaxis after major trauma: potential cost implications. Crit Care Med 2001;29:1659-65.
20. Schmidt F, Faul C, Dichgans J, Weller M. Low molecular weight heparin for deep vein thrombosis in glioma patients. J Neurol 2002;249:1409-12.
21. Knudson MM, Lewis FR, Clinton A, Atkinson K, Megerman J. Prevention of venous thromboembolism in trauma patients. J Trauma 1994;37:480-7.
22. Major KM, Wilson M, Nishi GK, Farber A, Chopra R, Chung A et al. The incidence of thromboembolism in the surgical intensive care unit. Am Surg 2003;69:857-61.
23. Ginzburg E, Cohn SM, Lopez J, Jackowski J, Brown M, Hameed SM et al. Randomized clinical trial of intermittent pneumatic compression and low molecular weight heparin in trauma. Br J Surg 2003;90:1338-44.
24. Alejandro KV, Acosta JA, Rodriguez PA. Bleeding manifestations after early use of low-molecular-weight heparins in blunt splenic injuries. Am Surg 2003;6: 1006-9.
25. nd et al. The prevalence of venous thromboembolism of the lower extremity among thermally injured patients determined by duplex sonography. J Trauma 2003;55:1162-7.
26. Kadyan V, Clinchot DM, Mitchell GL, Colachis SC. Surveillance with duplex ultrasound in traumatic spinal cord injury on initial admission to rehabilitation. J Spinal Cord Med 2003;26:231-5.
27. Kadywan V, Clinchot DM, Colachis SC. Cost-effectiveness of duplex ultrasound surveillance in spinal cord injury. Am J Phys Med Rehabil 2004;83:191-7.
28. Juul K, Tybjaerg-Hansen A, Schnohr P, Nordestgaard BG. Factor V Leiden and the risk for venous thromboembolism in the adult Danish population. Ann Intern Med 2004;140:330-7.
29. Frezza EE. Venous thromboembolism after pentrating chest trauma is not a cause of early death. J Cardiovasc Surg 1996;37:521-4.
30. Sonpal IM, Patterson L, Schreiber H, Benmeir A. Mesenteric venous thrombosis after gastric bypass. Obes Surg 2004;14:419-21.
31. Dresel A, Kuhn JA, McCarty TM. Laparoscopic Roux-en-Y gastric bypass in morbidly obese and super morbidly obese patients. Am J Surg 2004;187:230-2.
32. Higa KD, Boone KB, Ho T. Complications of the laparoscopic Roux-en-Y gastric bypass: 1 040 patients-what have we learned? Obes Surg 2000;10:509-13.
33. Scholten DJ, Hoedema RM, Scholten SE. A comparison of two different prophylactic dose regimens of low molecular weight heparin in bariatric surgery. Obes Surg 2002;12:19-24.
34. Gleysteen JJ, Bandyk DF, Hussey CV, Naftel DC. Perioperative coagulation changes with gastric bypass: association with venous thrombosis? Obes Surg 1993;3:7-14.
35. Moose D, Lourie D, Powell W, Pehrsson B, Martin D, LaMar T et al. Laparoscopic Roux-en-Y gastric bypass: minimally invasive bariatric surgery for the superobese in the community hospital setting. Am Surg 2003;69: 930-2.
36. DeMaria E, Sugerman H, Kellum J, Meador J, Wolfe L Results of 281 Consecutive Total Laparoscopic Roux-en-Y Gastric Bypasses to Treat Morbid Obesity. Ann Surg 2002;235:640-7.
37. Kreitz K, Rovito P. Laparoscopic Roux-en-Y Gastric Bypass in the "Megaobese". Arch Surg 2003;138:707-9.
38. Melinek J, Livingston E, Cortina G, Fishbein MC. Autopsy findings following gastric bypass surgery for morbid obesity. Arch Pathol Lab Med 2002;126:1091-5.
39. Schauer PR, Ikramuddin S, Gourash W, Ramanathan R, Luketich J. Outcomes after laparoscopic Roux-en-Y gastric bypass for morbid obesity. Ann Surg 2000;232: 515-29.
40. Westling A, Bergqvist D, Bostrom A, Karacagil S, Gustavsson S. Incidence of deep venous thrombosis in patients undergoing obesity surgery. World J Surg 2002;26:470-3.
41. Gonzalez QH, Tishler DS, Plata-Munoz JJ, Bondora A, Vickers SM, Leath T et al. Incidence of clinically evident deep venous thrombosis after laparoscopic Roux-en-Y gastric bypass. Surg Endosc 2004;18:1082-4.